Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

NCT04932291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: vafidemstat
DRUG: Placebo

Sponsor

Oryzon Genomics S.A.